- Home
- NBP vs REFI Comparison
NBP vs REFI Comparison
Compare NBP & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBP | REFI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 240.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NBP | REFI |
|---|---|---|
| Price | $1.49 | $11.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 646.2K | 97.1K |
| Earning Date | 04-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | N/A | $17.47 |
| Revenue Next Year | N/A | $0.06 |
| P/E Ratio | ★ N/A | $49.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $10.74 |
| 52 Week High | $5.19 | $14.62 |
Technical Indicators
Market Signals| Indicator | NBP | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 26.54 | 48.21 |
| Support Level | N/A | $11.03 |
| Resistance Level | $1.95 | $11.54 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 6.19 | 68.63 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.